RSCM
SGMT icon

Rock Springs Capital Management’s Sagimet Biosciences SGMT Stock Holding History

Rock Springs Capital Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
+250,000
New +$1.7M 0.09% 91
2025
Q2 		– Sell
-787,808
Closed -$2.57M – 100
2025
Q1 		$2.57M Hold
787,808
– – 0.15% 75
2024
Q4 		$3.55M Hold
787,808
– – 0.14% 83
2024
Q3 		$2.18M Hold
787,808
– – 0.07% 97
2024
Q2 		$2.69M Buy
787,808
+17,137
+2% +$78.6K 0.08% 98
2024
Q1 		$4.18M Buy
770,671
+32,316
+4% +$232K 0.11% 96
2023
Q4 		$4M Hold
738,355
– – 0.1% 84
2023
Q3 		$6.5M Buy
+738,355
New +$9.83M 0.17% 80

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Rock Springs Capital Management's SGMT Position: Q2 2026 in Review

Rock Springs Capital Management opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 250,000 shares worth $1.93M. The stake represents 0.09% of the portfolio and ranks #91 among its holdings. This is a return to the name: Rock Springs Capital Management previously reported a position in SGMT as recently as Q1 2025.

Rock Springs Capital Management first reported a position in SGMT in Q3 2023 and has held it in 8 quarters since. The position peaked at $6.5M in Q3 2023. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Rock Springs Capital Management held 250,000 shares of Sagimet Biosciences worth $1.93M as of Q2 2026.
  • Sagimet Biosciences was a new Rock Springs Capital Management position in Q2 2026.
  • Sagimet Biosciences made up 0.09% of Rock Springs Capital Management's portfolio in Q2 2026, its #91 holding.
  • Rock Springs Capital Management first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 8 quarters since.
  • Rock Springs Capital Management's Sagimet Biosciences position peaked at $6.5M in Q3 2023.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.